European Journal of Cancer
Volume 41, Issue 4 , Pages 491-501, March 2005

New science-based endpoints to accelerate oncology drug development

  • Gary J. Kelloff

      Affiliations

    • Division of Cancer Treatment and Diagnosis, Cancer Imaging Program, National Cancer Institute, Executive Plaza North Room 6038, 9000 Rockville Pike, Bethesda, MD 20892, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 301 594 0423; fax: +1 301 480 3507
    • ,
  • Caroline C. Sigman

      Affiliations

    • CCS Associates, Mountain View, CA, USA

Received 16 November 2004; accepted 6 December 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(04)00993-1

doi:10.1016/j.ejca.2004.12.006

European Journal of Cancer
Volume 41, Issue 4 , Pages 491-501, March 2005

Article Tools